In animal embryos, cells transition from a multipotential state, with the capacity to adopt multiple fates, into an irreversible, committed state of differentiation. This multipotency-to-commitment transition (MCT) is evident from experiments in which cell fate is reprogrammed by transcription factors for cell type-specific differentiation, as has been observed extensively in Caenorhabditis elegans. Although factors that direct differentiation into each of the three germ layer types cannot generally reprogram cells after the MCT in this animal, transcription factors for endoderm development are able to do so in multiple differentiated cell types. In one case, these factors can redirect the development of an entire organ in the process of "transorganogenesis". Natural transdifferentiation also occurs in a small number of differentiated cells during normal C. elegans development. We review these reprogramming and transdifferentiation events, highlighting the cellular and developmental contexts in which they occur, and discuss common themes underlying direct cell lineage reprogramming. Although certain aspects may be unique to the model system, growing evidence suggests that some mechanisms are evolutionarily conserved and may shed light on cellular plasticity and disease in humans.
In animal embryos, cells transition from a multipotential state, with the capacity to adopt multiple fates, into an irreversible, committed state of differentiation. This multipotency-to-commitment transition (MCT) is evident from experiments in which cell fate is reprogrammed by transcription factors for cell type-specific differentiation, as has been observed extensively in Caenorhabditis elegans. Although factors that direct differentiation into each of the three germ layer types cannot generally reprogram cells after the MCT in this animal, transcription factors for endoderm development are able to do so in multiple differentiated cell types. In one case, these factors can redirect the development of an entire organ in the process of "transorganogenesis". Natural transdifferentiation also occurs in a small number of differentiated cells during normal C. elegans development. We review these reprogramming and transdifferentiation events, highlighting the cellular and developmental contexts in which they occur, and discuss common themes underlying direct cell lineage reprogramming. Although certain aspects may be unique to the model system, growing evidence suggests that some mechanisms are evolutionarily conserved and may shed light on cellular plasticity and disease in humans.
Keywords: Caenorhabditis elegans; cellular plasticity; cellular reprogramming; transdifferentiation; transorganogenesis Development begins with a single totipotent cell, the fertilized zygote, poised with the potential to become any type of cell within the organism. Through successive cell divisions, embryonic cells undergo binary or multipotential fate decisions, with progressively more restricted levels of specification. During this process, particular cellular contexts are established that restrict cell fate potential, culminating in cells with fully committed differentiated identities. This progressive restriction of cell fate is driven by the stepwise mobilization of transcription factors that comprise key regulatory nodes in gene regulatory networks.
The transformation of a zygote into a multicellular organism, containing a broad range of specialized cell types, is marked by major developmental transitions that have been illuminated in a variety of animal embryos. These include the oocyte-to-embryo transition, during which the developmental program for oogenesis is replaced by the program to initiate development of a multicellular embryo [1] . Later, the midblastula transition (MBT) [2] is activated, during which (particularly notably in vertebrates) the nuclear DNA : cytoplasm ratio triggers widespread transcriptional activation of a previously largely quiescent Abbreviations DTC, distal tip cell; ESC, embryonic stem cells; MBT, mid-blastula transition; MCT, multipotency-to-commitment transition; MZT, maternalto-zygotic transition; PRC, polycomb repressive complex; RBCC, ring finger B-box and coiled-coil; TRIM-NHL, tripartite motif and Ncl-1, HT2A, and Lin-41 domain.
nucleus. This event leads to the process that occurs more generally in all embryos: the maternal-to-zygotic transition (MZT) [3, 4] , characterized by the activation of the embryonic genome, concomitant with elimination of a substantial fraction of the maternal factors that had been laid down in the oocyte during germline development [1, [5] [6] [7] . These latter processes also correlate with loss of developmental plasticity, whereby the initial ability of cells to adopt a wide range of fates becomes progressively more restricted. Subsequent to these early events, cells undergo dramatic rearrangements in a further major transition known as gastrulation, which establishes the embryonic germ layers [8] .
As we highlight in studies of Caenorhabditis elegans, by probing cellular plasticity in animal embryos it is also possible to discern another major embryonic transition, the multipotency-to-commitment transition (MCT) [9] [10] [11] . Understanding the MCT is pivotal to our knowledge of cell fate commitment, developmental plasticity, and the ability to reprogram cells. Studies of these critical processes benefit greatly from investigations in intact embryos, which provide an in vivo cellular context that is generally absent in most reprogramming studies [12, 13] . With the ability to track multiple cell and tissue types at the single cell level, and powerful molecular genetic tools that make it possible to assess both minor and more dramatic changes in cell fate, C. elegans is particularly well-suited for such investigations.
A broad spectrum of cellular reprogramming events have been observed in C. elegans, spanning all stages of the life cycle, both before and after the MCT, and occurring in many distinct cellular contexts (Fig. 1 ) [11, [14] [15] [16] [17] . This review addresses some of the major findings regarding developmental reprogramming in C. elegans, grouped by their cellular context, including forced reprogramming of early blastomeres, reprogramming of the germ line, transdifferentiation and transorganogenesis of somatic cells, and naturally occurring transdifferentiation. While there are no universal principles to these events, we discuss common themes, highlight the aspects that are thus far unique to C. elegans, and forecast the future translational impact of reprogramming studies that might emerge from studies in this model system.
The multipotency-to-commitment transition (MCT)
The ability to differentiate cells corresponding to the three classical germ layer types and the germline is differentially apportioned to a series of six "founder cells", which are established during the first several cell divisions in early C. elegans embryos. At the time of their birth, the founder cells appear to be specified to follow particular development pathways, as isolated founder cells that are allowed to develop in culture generate largely the same tissue types that they engender in intact embryos ( Fig. 1) [18] [19] [20] [21] . However, although founder cells and their descendants are specified, they are not committed to those fates and can undergo transdetermination. In fact, many studies have shown that progenitor cells produced well after the birth of the founder cells are multipotent and remain competent to follow different major developmental trajectories characteristic of all three germ layer types. Through much of early embryogenesis, most or all blastomeres can be reprogrammed to adopt a completely different fate when they ectopically express transcription factors that activate the development of very different lineages [22] [23] [24] [25] [26] . For example, ectopic expression of the GATA transcription factor END-1, which is redundantly required to specify the endoderm founder cell [27] , provokes virtually all embryonic cells to adopt an endodermal fate, resulting in an embryo composed entirely of gut [24] . In such embryos, essentially all other pathways of differentiation are repressed, indicating that the normal development of nonendodermal cells is redirected into the gut differentiation pathway. Similarly, ectopic expression of the ectoderm-promoting GATA transcription factors ELT-1 or ELT-3, and the mesodermal factor HLH-1, a homolog of the MyoD family of muscle differentiation factors, causes virtually the entire embryo to develop into skin [22] and muscle [23] , respectively. Furthermore, PHA-4/FoxA can activate pharynx development in many cells normally destined to adopt other fates [25] . These studies demonstrate that embryonic cells remain pluripotent, that is, capable of giving rise to cells of all three germ layer types, well after the founder cells are born and specified.
These studies also revealed that the ability of embryonic cells to undergo developmental reprogramming is temporally limited to the early stages of embryogenesis. Specifically, the competency of somatic blastomeres to become reprogrammed into other cell types is rapidly lost starting at the~100-cell stage (i.e., when the founder cell of the entire endoderm, or E cell, has undergone two rounds of division, henceforth referred to as the 4E stage). By the~200-cell (8E) stage, all blastomeres appear to have transitioned to a committed state and cannot generally be reprogrammed by transcription factors that direct unrelated developmental pathways. These experiments reveal that a MCT occurs during the first half of embryogenesis (Fig. 1) . This transition correlates with changes in the compaction of chromatin within the nucleus [28, 29] . A similar event likely occurs in most or all animal embryos [30] [31] [32] [33] [34] [35] .
The existence of the MCT might indicate that gene regulatory networks appropriate for each cell lineage establish molecular "lockdown" switches (e.g., through positive autoregulation of transcription factors that activate cell type-specific gene expression and differentiation; [36, 37] ) for restricted pathways of differentiation. The lockdown structure of such regulatory networks might resist mobilization of heterologous cell fate-determining gene networks that can be activated by ectopic transcription factor expression prior to the MCT. In addition to the architecture of gene regulatory networks, changes in chromatin organization that preclude transcription factors from accessing their target genes, also restrict developmental plasticity. Studies in C. elegans suggest that such processes contribute at least partially to the MCT.
Molecular control of the MCT and temporal extension of cellular plasticity
Mechanisms underlying the MCT have been probed by genetically screening for factors required for its normal onset based on the notion that debilitation of such components would be correlated with altered developmental plasticity [28, 38] . Cells in embryos lacking these factors might be expected to differentiate A major developmental transition, the MCT, then occurs, after which blastomeres are committed to their respective specified fates (blue background). Multipotency can be extended temporally, resulting in a delayed MCT with respect to developmental progress, through inhibition of PRC2 or Notch signaling (red text). Post-MCT cell fates can be converted through natural or forced transdifferentiation (arrows). Inhibition of MEX-3 and GLD-1, or inhibition of MES-2 causes germ cells to spontaneously differentiate, resulting in teratomas. Inhibition of LIN-53 or PRC2, in combination with forced expression of CHE-1, causes germ cells to be reprogrammed into neurons, and conversion can be enhanced by increasing Notch signaling (blue text). Forced expression of ELT-7 (or ELT-2, or END-3) causes transdifferentiation of the fully differentiated and functional pharynx, and transorganogenesis of the developing somatic gonad, into intestine, with the uterus forming a secondary gut-like organ (orange text). During larval development, a single epithelial cell ("Y") undergoes programmed transdifferentiation into a neuronal cell ("PDA") through a natural process involving numerous identified factors; during male-specific larval development the glial amphid socket cells ("AMso") undergo an additional cell division, in which one daughter self-renews as a glial cell while the other loses glial characteristics and acquires neuronal characteristics, and transdifferentiates into a male-specific neuron ("MCM") (green text). Loss of gene function is indicated by (À) and gain of function or forced expression is indicated by (+++).
normally but should be susceptible to reprogramming by ectopic transcription factor expression later than normal.
Based on this logic, the mes-2 gene was identified by Yuzyuk et al. [28] as being a global inhibitor of cell fate plasticity during embryonic development. MES-2, the worm homolog of Drosophila Enhancer of zeste, is the catalytic component of a Polycomb repressive complex (PRC). The authors observed that forced expression of the muscle-promoting transcription factor HLH-1, which activates muscle differentiation in ectopic lineages when expressed prior to, but not after, the MCT in 8E embryos, led to a significantly higher proportion of embryos showing widespread expression of a muscle-specific marker and the absence of a pharynx-specific marker in mes-2 mutants. Transcriptional profiling of 2E, 4E, and 8E stage embryos revealed that mes-2 mutants fail to downregulate genes whose expression is normally temporally restricted to the 2E and/or 4E stages in wild-type embryos, suggesting that the early phase of gene expression, which is normally attenuated in the period leading up to the MCT, is extended in these mutants. A similar result was obtained in mutants defective for MES-3, which encodes another PRC2 component. A change in the extent of chromatin condensation was inferred to occur around the time of the MCT, based on a decrease in the intranuclear distance between nuclear sites tagged with a fluorescent protein. In mes-2(À) mutant embryos, this effect was diminished; that is, the nuclear fluorescent tags remained more distant. This observation was taken to mean that the PRC2 complex promotes remodeling of chromatin into a state that restricts the accessibility of the genome to cell fate-determining transcription factors.
These findings imply that the mechanisms that regulate conversion of embryonic cells from a developmentally plastic to a committed state can be at least partially uncoupled from the events controlling cell fate per se. Despite the extension in the period of developmental plasticity, perdurance of transcriptional signatures of early embryogenesis, and a failure to undergo normal compaction, mes-2 null mutant embryos are viable, and activation of zygotic genes appears to occur normally. These findings imply that commitment does not solely reflect activation of lockdown circuits in gene regulatory networks that control cell identity: developmental events, such as activation of zygotic gene expression, do not specifically define the transition from multipotency to commitment. Indeed, initiation of cell fate specification does not appear to define the onset of the MCT, since by the 8E-cell stage, many tissue-specific markers are expressed in their respective progenitor cell lineages, and yet cells can be fully transdetermined into several possible cell fates. The H3K27 methyltransferase MES-2 is proposed to globally regulate chromatin reorganization, and perhaps it is this architectural restructuring that determines the onset of the MCT.
The MCT is not exclusively controlled by global mechanisms, such as chromatin remodeling by the PRC2 complex. Rather, in certain lineages, there are additional factors that can determine the point in development in which a lineage becomes committed [38] . Specifically, Notch signaling, which acts recursively throughout the lineage of the AB founder cell to specify particular cell identities, was found to be required to establish a memory state during development that later determines the timing of onset of the MCT. Using a temperature-sensitive mutant of GLP-1/Notch, Djabrayan et al. [38] demonstrated that when Notch signaling is eliminated during a critical early period of development, AB-derived blastomeres can be reprogrammed into the endoderm pathway well beyond the normal MCT. In the absence of Notch function, these cells instead maintain developmental plasticity as late as the 20E-cell stage. Unlike previously described roles for Notch in AB lineage specification [39] [40] [41] [42] [43] [44] , which involves reception of signals produced by descendants of P 1 (the sister cell of AB), this Notch-mediated restriction of plasticity is autonomous to the AB lineage, implying that both ligand and receptor in this event are expressed by AB descendants. Indeed, knockdown of dsl-3, which encodes a noncanonical DSL-like Notch ligand that is predicted to be secreted rather than be membrane associated, also resulted in AB autonomous extension in onset of the MCT. Thus, the function of Notch in AB fate specification, and in regulating developmental plasticity in the AB lineage, appears to be mediated by different sets of ligands. Furthermore, dsl-3 is not essential for embryonic viability, again suggesting that the mechanisms that establish the MCT are separable from those involved in cell fate specification and normal embryonic development.
This action of Notch in promoting differentiation and inhibiting plasticity is not limited to the C. elegans embryo: inhibition of Notch was shown to improve the efficiency of iPSC generation from mouse and human keratinocytes, removing the requirement for KLF4 and CMYC, and allowing for reprogramming by only SOX2 and OCT4 [45] . Additionally, similar to the AB lineage specificity of Notch in restricting plasticity in C. elegans, inhibition of Notch was not found to enhance iPSC generation from mouse embryonic fibroblasts, demonstrating the importance of cellular context in the effect of Notch on reprogramming potential.
Totipotency to commitment: reprogramming in the germline
The germline of C. elegans has proven to be a valuable model for investigating stem cell maintenance and regulation (for review see [11] ). The germline is organized in a developmentally linear manner. The somatic gonad is composed of two symmetrical U-shaped gonad arms. In the distal-most region of each arm, germ cell progenitors are maintained in a mitotic, proliferative state within a syncytium in response to a Notch signal from a somatic cell that creates the germline stem cell niche [46, 47] . As nuclei progress proximally and move away from the influence of this signal, they switch into a meiotic cell division program, arresting at the pachytene stage of Meiosis I, and complete oocyte maturation. As the oocyte possesses the potential to develop into all cells of the animal upon fertilization, there must exist mechanisms that keep this potential in check. Several such mechanisms have been illuminated in C. elegans and appear to involve mechanisms that are conserved across animal phylogeny.
A predominant mode of regulation during germline maturation and differentiation in C. elegans and other animals is translational control [48, 49] . Many maternal transcripts encoding regulators of embryonic fate specification and differentiation are synthesized during oogenesis. Thus, maintenance of totipotency relies critically on repression of these transcripts during germline development until fertilization and initiation of embryogenesis. The translational regulators GLD-1 and MEX-3 perform complementary functions in maintaining totipotency in the germline [50] . GLD-1, a STAR family of KH domain-containing RNA-binding proteins homologous to Quaking and Sam68, regulates the switch from mitosis to meiosis by inhibiting translation of promitotic and antidifferentiation proteins, including MEX-3 [51] . MEX-3 is expressed in a nonoverlapping pattern with GLD-1 in the germline and is predicted to regulate translation of multiple RNA-binding proteins, including the putative C. elegans homolog of human SOX2, which is required for embryonic stem cell (ESC) renewal and generation of induced pluripotent stem cells in mammals [52] [53] [54] [55] . It was found that simultaneous removal of gld-1 and mex-3 function causes spontaneous teratoma formation in the meiotic germline, that is, the premature differentiation of germline cells into differentiated cells from all three germ layer types (Fig. 1) . These factors likely function by repressing cell fate-determining transcription factors and modulating components that regulate chromatin and nuclear architecture, thereby preventing somatic differentiation during germline development.
As with embryos, the totipotency of the germline can be tapped to reprogram cells into somatic cell fates by forced expression of transcription factors [56] ; such approaches have revealed plasticity-regulating mechanisms that are common to both the germline and the embryo. While overexpression of a single transcription factor alone is insufficient to induce reprogramming of germ cells, ectopic expression of the neuronal selector zinc finger transcription factor CHE-1, in combinations with RNAi knockdown of LIN-53, the worm homolog of the histone-binding protein RbAp46/48, which participates in chromatin remodeling, results in directed conversion of germ cells into ASE-like gustatory neurons (Fig. 1) [56] . It was subsequently found that LIN-53 acts cell autonomously through MES-2/ MES-3/MES-6, the C. elegans PRC2, to prevent germ cell reprogramming [57] . Inhibition of PRC2 also allows germ cells to be reprogrammed into muscle cells when the muscle-determining HLH-1 transcription factor is expressed ectopically. PRC2, therefore, appears to function as a global repressor of cellular plasticity both in early embryos [28] and in the germline.
As in the embryo, Notch signaling has been shown to influence the propensity for germ cells to respond to reprogramming cues [58] ; however, in the opposite direction. Germline nuclei in the stem cell niche are maintained in a proliferative state through the action of Notch signaling from the distal tip cells (DTC) at the end of each gonad arm [59] . A gain-of-function mutation affecting GLP-1/Notch causes the germ cells to remain proliferative, resulting in germline tumors. In addition, GLP-1/Notch signaling enhances the conversion of germ cells into neurons in response to ectopic CHE-1 expression following knockdown of lin-53/ RbAp46/48 function [58] . It appears that the role of Notch signaling in promoting germ cell conversion into neurons can be uncoupled from its action in promoting germ cell proliferation: reprogramming of germ cells is not enhanced in Notch-independent germ cell proliferation mutants (i.e., in which stem cells divide even without Notch signal [60, 61] ). The separable Notch functions in this germ cell context is reminiscent of the independent roles of Notch in the embryonic AB lineage context, in which it separately promotes cell fate specification and regulates developmental plasticity [38] . However, it is not clear whether, as in the latter case, there are distinct Notch ligands that mediate these two roles in the germline.
Analysis of differential gene expression in GLP-1/ Notch loss-of-function and gain-of-function mutants suggests that Notch permits cell fate conversion by opposing PRC2 action. One identified focal point in this antagonistic relationship is UTX-1, a JmjC domain-containing H3K27me3 demethylase; PRC2 silences utx-1 expression, while Notch signaling activates its expression [58] . utx-1 transcription is critical for Notch-enhanced germ cell conversion, and therefore, UTX-1 may be stimulated to promote reprogramming in the germ cell context.
Studies of germline totipotency in C. elegans have uncovered additional regulatory mechanisms of cellular plasticity that appear to be commonly used across phylogeny. The tripartite motif and Ncl-1, HT2A, and Lin-41 domain (TRIM-NHL) protein LIN-41, a novel ring finger B-box and coiled-coil (RBCC) protein that was originally identified as a key heterochronic regulator of larval somatic cell fate [62] , is essential to prevent oocytes from prematurely transitioning into embryonic development [63] . Loss of LIN-41 in the germline results in inappropriate activation of the embryonic genome, transition from the meiotic to mitotic cell cycle, and somatic-like differentiation, resulting in teratoma formation. LIN-41 is thought to regulate totipotency in oocytes at the post-transcriptional and/or post-translational level in the cytoplasm, although the precise mechanism is not yet clear [63] . The Drosophila TRIM-NHL homologs, Mei-P26 [64] and Brat (Brain Tumor) [65] , are also specifically associated with cells that have switched from a stem cell state and are undergoing differentiation in the ovary and in asymmetrically dividing neuroblast cells, respectively. Loss of Mei-P26 causes the transit-amplifying ovarian cells to proliferate indefinitely, forming a tumor [64] . Brat is asymmetrically segregated to one of the neuroblast cells, where it promotes differentiation and inhibits self-renewal. In the absence of Brat, the transit-amplifying neural progenitor cells continue dividing, forming a tumor [65, 66] . Similarly, the murine homolog of these proteins, TRIM32, maintains a balance between self-renewal and differentiation of neural progenitor cells in the neocortex via degradation of proteins such as cMyc by ubiquitination, and an increase in differentiation-promoting miRNA activity, including Let-7 [67] . The Let-7 miRNA has also been shown to inhibit reprogramming of differentiated cells into pluripotent human iPS cells: inhibition of Let-7 promotes the OCT4-SOX2-KLF4-mediated reprogramming by inhibiting translation of the prodifferentiation factor EGR1 [68] . Collectively, these observations suggest that Lin-41/microRNA constitute a conserved pathway that regulates the balance between renewal of pluripotent cells and differentiation.
Violating the MCT: somatic reprogramming of fully differentiated cells by ELT-7
The fully differentiated, postmitotic somatic cells of C. elegans generally maintain a stable cell fate, with the notable exception of two that undergo determinate programmed transdifferentiation (reviewed below). As differentiation of all cells occurs after the MCT, differentiated somatic cells are generally resistant to the type of forced reprogramming that can be observed in developmentally plastic pre-MCT blastomeres in early embryos. While most cells of the newly hatched larva become fully differentiated and postmitotic prior to the end of embryogenesis, many continue to divide and develop throughout postembryonic development, long after the MCT. Nonetheless, although these cells and their descendants do not differentiate until later in larval development, they have not been found to be widely plastic. However, particular fully differentiated or developing cells are permissive to forced transdifferentiation in response to specific transcription factors.
The GATA transcription factor ELT-7 has been shown to be capable of overriding the MCT and promoting transdifferentiation of postmitotic nonintestinal cells into gut-like cells at any stage of development, including in adults (Fig. 1) [9, 10] . ELT-7 is normally expressed exclusively in the E-cell lineage and throughout the life of the animal in the differentiated gut. It functions as a terminal component of the endoderm gene regulatory network [36, 69] , downstream of the END-1 GATA factor and redundantly with the ELT-2 GATA factor, to initiate gut differentiation during embryogenesis and to maintain transcription of intestinal genes. While ubiquitous expression of various cell fate-determining transcription factors after the MCT has not been reported to initiate target gene expression, a brief pulse of ELT-7 expression at any stage in C. elegans development results in widespread transient activation of an elt-2 gene reporter in many cells throughout the animal, indicating that ELT-7 is able to access and activates its targets even in fully differentiated, nonendodermal cells. While this expression gradually fades over the ensuing 48 h, it persists in cells of two organs-the proximal somatic gonad, and the muscular feeding organ, or pharynx-where it is associated with stable transdifferentiation and remodeling of the affected cells. Although the END-1 GATA factor cannot trigger transdifferentiation after the MCT, additional members of the endoderm gene regulatory network, END-3 and ELT-2, also GATAtype transcription factors, are similarly capable of inducing transdifferentiation in C. elegans, albeit with somewhat reduced efficacy compared to ELT-7 [10] . It is conceivable that the unusually small size of ELT-7 (198 amino acid residues) or other structural characteristics may allow it to access promoters in an otherwise inaccessible chromatin context and thus contribute to its capacity to promote efficient transdifferentiation of differentiated cells.
In the case of the somatic gonad, brief ubiquitous expression of ELT-7 during mid-to-late larval stages redirects the development of the hermaphrodite uterus and spermathecae, and the male vas deferens, all of which arise from equivalent somatic gonadal cell lineages, into a well-formed intestine-like organ (Fig. 2 ) [10] . Within the uterus, an intestine-specific intermediate filament protein, which is normally expressed during terminal differentiation of the embryonic gut [70] , is activated and contributes to the formation of an ectopic intestinal lumen-like structure [10] . Electron microscopy of the reprogrammed uterus revealed that it is virtually indistinguishable at the fine ultrastructural level from the normal intestine, including the features of an intestine-like terminal web and microvilli; hence, the developing proximal gonad appears to undergo conversion into a morphologically normal gut in the process of "transorganogenesis". The order and relative timing of these events are similar to those during normal embryonic gut development, suggesting that this process of transorganogenesis involves redeployment of the normal embryonic gut development program. It is of particular note that the de novo genesis of an intestine-like organ can occur in a very different context from the normal process: instead of forming within an embryo from na€ ıve, undifferentiated blastomeres, it can be created from a nearly fully developed organ of an entirely different identity. It remains to be determined whether transorganogenesis results in a fully functional gut organ.
The ability to provoke gut development in the developing gonad is limited to the L3-L4 stages of larval development, the period in which the majority of uterine organogenesis, including cellular proliferation, occurs. At the time of hatching, the somatic gonad consists of only two precursor cells, Z1 and Z4, which subsequently divide during larval development into a total of 143 cells, with the uterus alone containing 60 cells [71] . Prior to the L3 larval stage, the 12 cells that compose the somatic primordium of the hermaphrodite appear to be insensitive to forced reprogramming. The developmental window for uterus-to-intestine transorganogenesis ceases by the end of the L4 larval stage, just prior to adulthood. Interestingly, in contrast to the uterus, the spermathecae can apparently be reprogrammed into intestine well into adulthood. The cellular context of the developing uterus may be analogous to early blastomeres, which have not yet traversed the MCT. Regardless, these cells are not widely plastic: forced expression of HLH-1 or ELT-1 is unable to reprogram developing uterine cells into muscle or epidermis, respectively. Also, as evidenced by the copresence of ectopic ELT-2 protein and EGL-13/ SOX domain transcription factor in a subset of uterine cells, intestine-specific reprogramming can be initiated by ELT-7 in actively differentiating cells [72] .
Ectopic ELT-7 is also capable of reprogramming fully differentiated and functional cells in the pharynx [9] . Similar to the cells of the somatic gonad, intestineand pharynx-specific reporter expression and ultrastructural analysis indicate loss of pharyngeal cellular identity occurs contemporaneously with acquisition of intestinal cellular identity, suggesting the pharynx undergoes bona fide transdifferentiation. However, in contrast to transorganogenesis of the uterus, pharyngeal cells are susceptible to forced transdifferentiation at any larval stage and throughout adulthood [9] . It is noteworthy that the pharynx is fully formed, postmitotic, and becomes functional by the end of embryogenesis. Although it grows larger, it does not undergo further development during larval stages. Hence, the conversion of pharynx cells into gut-like cells by a single transcription factor can occur in terminally differentiated, postmitotic cells that have been functioning for several days.
In contrast to many other examples of transdifferentiation and reprogramming, these observations demonstrate that (a) a single transcription factor is capable of provoking transdifferentiation, (b) transdifferentiation occurs without a requirement for removing any other factors, and (c) it can occur in postmitotic cells, without a requirement for intercession of a cell division cycle. In addition, this event is associated with wholesale remodeling of cellular ultrastructure.
The specificity of cell fate switching from pharynxto-intestine and uterus-to-intestine may be attributable to the endogenous expression of another factor that establishes a permissive cellular context in which ELT-7 can direct intestine fate. One candidate for such a second factor is the C. elegans FoxA transcription factor homolog PHA-4, which is known to be expressed in the intestine, pharynx, and developing somatic gonad, and has been extensively studied in the context of its essential role in pharynx organogenesis [25, [73] [74] [75] [76] [77] . Although knockdown of PHA-4 during larval development was not found to significantly reduce levels of forced reprogramming to the intestine of either organ, elimination of PHA-4 during embryonic development, which prevents formation of a differentiated pharynx, was found to block transdifferentiation [10] . This result suggests that PHA-4 activity may not be required at the time of ELT-7 induction for cell fate change to occur, but that normal PHA-4-dependent pharynx differentiation is a necessary condition for pharynx transdifferentiation.
Reprogramming of somatic cells into intestinal cells in C. elegans, as with any example of cellular reprogramming, raises the question of whether the adopted cell fate is molecularly identical to the normal cells of the same fate, as defined by transcriptional and chromatin state, or if there remains a "memory" or remnant transcriptional activity persisting from the original fate. The reprogramming of somatic cells with a single transcription factor in vivo provides a model for investigating the mechanisms of directed cell fate change. How is the expression of a single transcription factor alone capable not only of initiating the endoderm differentiation network within an abnormal cellular context but also repressing the endogenous cell fate network? Transient coexpression of genes that are never normally expressed in the same cells during development must be reconciled to resolve into a stable cell fate. The activation of the gut differentiation program and simultaneous suppression of the endogenous transcriptional program occurs through a mechanism that is yet unknown. It is possible that cell fate conversion relies on extensive protein turnover, which removes the factors specific to the initial fate (Fig. 2) . During normal embryonic development, proper cell fate decisions often depend on protein degradation through Cullin-RING ubiquitin ligase E3 complexes [78] . Such turnover may be essential for efficient transdifferentiation.
Commitment to unipotency: naturally occurring reprogramming
Cellular reprogramming in C. elegans has been shown to occur not only as a result of artificial experimental conditions but also during normal development in cells that undergo preprogrammed, and highly stereotyped, transdifferentiation. The ability to track single cells continuously throughout C. elegans development allows unambiguous assignment of these transdifferentiation events, providing a fruitful model for such bona fide plasticity in differentiated cells. In these cases of natural transdifferentiation, fully differentiated and functional epithelial (Y cell) or glial cells (AMso) later convert into a motor neuron (PDA) and a sensory neuron (MCM), respectively (Fig. 1) [79, 80] . One of these two transdifferentiation events has been characterized at the molecular level, providing substantial insights into the process. Long after the MCT, when all cells have committed to a particular cell fate or lineage and widespread cellular plasticity has been lost, the rectal epithelial "Y" cell proceeds through a stepwise process in which it dissociates and migrates away from the rectal tube, undergoes dedifferentiation and loss of its epithelial characteristics, and then redifferentiates into the "PDA" motor neuron, which expresses characteristic neuronal markers and morphology [81] . As these events have been extensively reviewed, we will briefly summarize these studies here; for additional reviews see [15] [16] [17] 82] .
Studies of the Y?PDA event have revealed remarkable conservation in mechanisms that regulate cellular plasticity in distantly related metazoans. Through a combination of forward and reverse genetic screens for C. elegans mutants that show a persistent Y cell fate, it was found that the initiation of Y?PDA transdifferentiation requires the activity of a chromatin-modifying NODE (Nanog and Oct4-associated Deacetylase)-like complex containing SEM-4/Sall, CEH-6/Oct4, and EGL-27/MTA, along with SOX-2/Sox activity [83] . As members of this complex have been shown to be involved in pluripotency of mammalian ESCs [84] [85] [86] , this finding provides a striking link between mechanisms involved in ESC plasticity in mammals and natural transdifferentiation in an animal that has diverged from them since the split of protostomes and deuterostomes~6-700 Mya. In C. elegans, these factors appear to function upstream of the homeodomain-containing transcription factor EGL-1, which is further required for an early step in the Y?PDA identity change [79, 83] . The dedifferentiated Y?PDA intermediate exists for only a brief period in development, and is devoid of nearly all epithelial and neuronal markers and morphological characteristics. Nonetheless, this intermediate appears to be unipotent, and its fate, tightly regulated. Challenging the unipotent cell through forced expression of intestine or muscle fate-directing transcription factors fails to redirect its differentiation; transdifferentiation only to the PDA fate has been observed for this cell [81] . Thus, in this in vivo cellular reprogramming context, loss of differentiated cell identity is apparently uncoupled from acquisition of multipotency.
Chromatin factors have also been shown to be intimately involved in other aspects of Y?PDA transdifferentiation, with their activity regulated at different stages of the process. In early Y?PDA, H3K4 methylation occurs through the C. elegans Set1 complex, which includes set-2 and wdr-5.1 among others, and findings suggest that the Set1 complex also interacts with the aforementioned NODE factors [87] . In later stages of Y?PDA conversion, H3K4 methylation is accompanied by H3K27me3/2 demethylation by JMJD-3.1/KDM6B, which can physically interact with both WDR-5.1, and UNC-3/EBF, a transcription factor required for redifferentiation to a neuronal fate [81, 87] .
The ability of the Y rectal epithelial cell to undergo transdifferentiation is established when the cell is born during embryogenesis and appears to be triggered by LIN-12/Notch signaling [79] . In constitutively active lin-12 mutants, the sister of Y also adopts a Y cell fate, and later in development animals with two PDA neurons are observed, indicating that both Y cells have undergone transdifferentiation. By using a temperature-sensitive lin-12 mutant, Jarriault et al. [79] demonstrated that if Notch function is eliminated after Y cell fate has been established, but before initiation of transdifferentiation, a PDA cell can still arise. Thus, while Notch is required for induction of Y cell fate, it is dispensable for the transition to neuronal cell fate. This Notch functionality may be analogous to the role of Notch signaling in germ cell conversion by antagonizing the repressive heterochromatin state established by PRC2 through expression of histone demethylases [58] . Notch signaling may similarly establish a "memory state" in the Y cell which later permits the Y cell to lose its differentiated identity and gain plasticity (unipotential in this case).
A second example of natural transdifferentiation in C. elegans involves the sex-specific conversion of fully differentiated and functional glial cells, the bilateral AMso cells, into male-specific neurons, the MCMs, which are involved in a sexual conditioning behavior [80] . In hermaphrodites, the AMso cells are terminally differentiated and do not undergo this event; plasticity of these cells is triggered during late larval development by the sex-determination pathway. The AMso? MCM transdifferentiation event differs from that of the postmitotic Y? PDA event in that a round of cell division precedes acquisition of the new cellular identity. The molecular events underlying AMso? MCM transdifferentiation have not yet been elucidated and it will be of interest to learn whether similar mechanisms to those directing transdifferentiation of Y are involved.
Conclusions and perspectives
A diversity of cellular reprogramming strategies are now known in C. elegans. Although no universal mechanisms have emerged, common themes are evident. It is likely that in some cases the in vivo cellular context provides a reprogramming-competent state that permits cell fate conversion to a particular end. In mice, induction of murine cardiomyocyte-like cells by Gata4, Mef2c, and Tbx5 overexpression is inefficient in vitro but much more robust in vivo [88, 89] . This type of cellular environment-enhanced reprogramming in C. elegans could be involved in, for example, transorganogenesis of the uterus into intestine. However, cell-autonomous mechanisms act in other settings, such as PRC2-mediated inhibition of germ cell reprogramming [57] .
It is not unexpected that epigenetic regulation has been implicated as a key mechanism in the MCT and in nearly all reprogramming events in C. elegans, often functioning as an "epigenetic barrier" (e.g., [90] ). In blastomere reprogramming, cells are initially intrinsically plastic, and heterochromatin is not readily observed. PRC2 activity initiates commitment and loss of plasticity, and is a major contributor to the MCT. In germline reprogramming, totipotency is maintained largely through post-transcriptional and post-translational regulation [48, 91] , although a role is also played by epigenetic silencing mechanisms which, if inhibited, can allow directed acquisition of cell fate. Natural transdifferentiation involves stepwise action of epigenetic modifications, and while not absolutely required for successful transdifferentiation, they ensure robust cell fate conversion. In contrast, for somatic reprogramming initiated by ELT-7, removal of inhibitory chromatin marks is remarkably not a necessary step. The specificity of ELT-7-mediated reprogramming into intestine could, however, be aided by an intrinsic absence of repressive chromatin, recruitment of endogenous chromatin-modifying complexes, or early expression of a tissue-specific chromatin remodeller. With respect to the last possibility, transdifferentiation of mesoderm in mouse embryos into cardiomyocytes is achievable by ectopic expression of Gata4, Tbx5, and Baf60c-a cardiac-specific subunit of BAF chromatin remodeling complexes, which may permit binding of Gata4 to cardiac genes in unrelated cell types [92] .
Regarding the ability of ELT-7 to override the MCT, it is unclear how a single transcription factor is capable of inducing both transdifferentiation of the pharynx, and transorganogenesis of the somatic gonad, or why the latter is temporally restricted while the former is not. Although evidence suggests that deployment of intestinal differentiation follows a sequence similar to that in the embryo, the mechanism that promotes establishment of an ectopic cellular identity could be shared, or perhaps entirely distinct, depending on the cellular context. Also unclear is the response and ultimate fate of other cells and tissues that ectopically express transcriptionally active ELT-7 and an early readout of gut differentiation, yet do not show signs of a stable change in cell fate. Additional ectopic ELT-7 expression phenotypes include developmental arrest, impaired chemotaxis, and molting defects, suggesting that there may be more widespread changes in gene expression that disrupts normal functioning of epidermis and neurons, for example, but is insufficient for full transdifferentiation into intestine. This could be the result of additional repressive mechanisms that are not present in the pharynx or somatic gonad. If so, then removal of such factors might make it possible to reprogram many more, or even all cells of the animal.
A particularly unusual characteristic of reprogramming identified in C. elegans is the requirement for the establishment of a fully differentiated cellular identity for successful transdifferentiation. This appears to be the case for both natural transdifferentiation, in which Notch-dependent specification of rectal epithelial cell fate is necessary for later conversion to neuronal cell fate [79] , and for forced transdifferentiation, in which PHA-4-dependent specification of pharyngeal cell fate is necessary for subsequent ELT-7-induced transdifferentiation to an intestinal cell fate [10] . Intriguingly, neither Notch nor PHA-4 appears to be required at the time of cell fate conversion. More likely these factors act to establish a permissive cellular context that allows endogenous or ectopic factors to initiate transdifferentiation. Interestingly, PHA-4/FoxA exemplifies a class of transcription factors called Pioneer factors that have been shown to bind to target sequences on nucleosomes associated with "silent" chromatin [93, 94] and can initiate the establishment of a chromatin state that is competent to be activated [95] . Similarly, the iPSC-promoting transcription factors Oct4 and Sox2, which are also required for Y? PDA transdifferentiation, behave as Pioneer factors by binding to transcriptionally silent chromatin sites in human fibroblasts prior to their transformation into iPSCs [96] .
Revealing the mechanisms that regulate cell fate plasticity in C. elegans has the potential to enhance our understanding of human disease. For example, some cell types appear to be more prone to conversion in fate which, in humans, can lead to metaplasias, the appearance of inappropriate differentiated tissue at ectopic sites [97, 98] . Indeed, Barrett's metaplasia, a precancerous condition linked to esophageal adenocarcinoma, in which the distal esophagus (foregut) is converted to intestine-like epithelium (midgut) [98] [99] [100] is analogous, and perhaps homologous, to the pharynx (foregut) ? intestine (midgut) transformation promoted by ELT-7 in C. elegans. Thus, the pharynx ? intestine transdifferentiation event might provide a useful model for understanding this metaplasia, particularly in light of the fact that the mechanisms that distinguish the major divisions (foregut, midgut, and hindgut) of the digestive tract appear to be largely conserved across metazoan phylogeny [101] .
Elucidating the mechanisms of reprogramming in C. elegans and their connections with the MCT may provide insights into conditions that involve inappropriate loss or gain of plasticity, resulting in impaired healing after injury, or oncogenesis. Studying cellular reprogramming in a model organism such as C. elegans also benefits from the ability to investigate the phenomena in an in vivo cellular context. In vivo reprogramming of cells to repair damaged or lost tissues has now been proposed as a potential treatment for various conditions, including ischemic injury and neurodegeneration [13, 88, [102] [103] [104] [105] [106] [107] [108] . Thus, more efficient and robust methods for converting tissues for regenerative medicine could greatly benefit from mechanistic understanding of cell fate commitment and lineage reprogramming in C. elegans and other model systems.
